Pimavanserin
ACP-103-048
Phase 2 small_molecule completed
Quick answer
Pimavanserin for Treatment of Depression in Adults With Parkinson's Disease (PD) is a Phase 2 program (small_molecule) at Acadia Pharmaceuticals B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Acadia Pharmaceuticals B.V.
- Indication
- Treatment of Depression in Adults With Parkinson's Disease (PD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed